Hypovitaminosis D and valvular calcification in patients with dilated cardiomyopathy

Dwight Dishmon, Jimmy L. Dotson, Ahmad Munir, Maeda D. Nelson, Syamal Bhattacharya, Ivan A. D'Cruz, Richard C. Davis, Karl Weber

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Background: In patients with dilated (idiopathic) cardiomyopathy (DCM), little is known about the presence of valvular calcification and its association with hypovitaminosis D, which may predispose affected tissues to calcification. Our objectives were 2-fold: to conduct a retrospective assessment of echocardiographic evidence of valvular calcification in patients with DCM who were known to have hypovitaminosis D (25(OH)D <30 ng/mL) and to conduct a prospective assessment of serum 25(OH)D in patients with DCM, who had demonstrated echocardiographic evidence of valvular calcification. Methods: The retrospective study consisted of 48 African American patients (34 men, 14 women; 52.3 ±1.5 years) having DCM and ejection fraction <35% with serum creatinine <2.0 mg/dL and 25(OH)D <30 ng/mL; and 20 white patients in the prospective study (20 men; 71.0 ± 3.0 years) having DCM and ejection fraction <35% with serum creatinine <2.0 mg/dL and echocardiographic evidence of valvular calcification. In the retrospective study, a transthoracic echocardiogram was obtained to address mitral valvular and annular calcification, aortic valvular calcification, and sinotubular calcification; whereas in the prospective study, serum 25(OH)D level was monitored in patients with known valvular calcification. Serum parathyroid hormone (PTH) was monitored in both studies. Results: In the retrospective study, hypovitaminosis D was found in 19 patients (31%) with valvular calcification and in whom serum PTH was increased (83 ± 8 pg/mL). In the prospective study, 15 of 20 elderly patients (80%) with known DCM and valvular calcification were found to have hypovitaminosis D (25(OH)D <30 ng/mL), whereas serum PTH was normal (43 ± 4 pg/mL). Conclusions: In patients with DCM without marked renal dysfunction, valvular calcification was seen more frequently and associated with hypovitaminosis D, whereas in elderly patients with valvular calcification, hypovitaminosis D is common, suggesting that the duration of vitamin D deficiency may determine the extent of valvular calcification. The role of hypovitaminosis D in the appearance of valvular calcification deserves further study.

Original languageEnglish (US)
Pages (from-to)312-316
Number of pages5
JournalAmerican Journal of the Medical Sciences
Volume337
Issue number5
DOIs
StatePublished - Jan 1 2009

Fingerprint

Dilated Cardiomyopathy
Cardiomyopathies
Serum
Parathyroid Hormone
Retrospective Studies
Prospective Studies
Creatinine
Vitamin D Deficiency
African Americans
Kidney

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Hypovitaminosis D and valvular calcification in patients with dilated cardiomyopathy. / Dishmon, Dwight; Dotson, Jimmy L.; Munir, Ahmad; Nelson, Maeda D.; Bhattacharya, Syamal; D'Cruz, Ivan A.; Davis, Richard C.; Weber, Karl.

In: American Journal of the Medical Sciences, Vol. 337, No. 5, 01.01.2009, p. 312-316.

Research output: Contribution to journalArticle

Dishmon, Dwight ; Dotson, Jimmy L. ; Munir, Ahmad ; Nelson, Maeda D. ; Bhattacharya, Syamal ; D'Cruz, Ivan A. ; Davis, Richard C. ; Weber, Karl. / Hypovitaminosis D and valvular calcification in patients with dilated cardiomyopathy. In: American Journal of the Medical Sciences. 2009 ; Vol. 337, No. 5. pp. 312-316.
@article{359638bf0d234aed8a4ba07a15376604,
title = "Hypovitaminosis D and valvular calcification in patients with dilated cardiomyopathy",
abstract = "Background: In patients with dilated (idiopathic) cardiomyopathy (DCM), little is known about the presence of valvular calcification and its association with hypovitaminosis D, which may predispose affected tissues to calcification. Our objectives were 2-fold: to conduct a retrospective assessment of echocardiographic evidence of valvular calcification in patients with DCM who were known to have hypovitaminosis D (25(OH)D <30 ng/mL) and to conduct a prospective assessment of serum 25(OH)D in patients with DCM, who had demonstrated echocardiographic evidence of valvular calcification. Methods: The retrospective study consisted of 48 African American patients (34 men, 14 women; 52.3 ±1.5 years) having DCM and ejection fraction <35{\%} with serum creatinine <2.0 mg/dL and 25(OH)D <30 ng/mL; and 20 white patients in the prospective study (20 men; 71.0 ± 3.0 years) having DCM and ejection fraction <35{\%} with serum creatinine <2.0 mg/dL and echocardiographic evidence of valvular calcification. In the retrospective study, a transthoracic echocardiogram was obtained to address mitral valvular and annular calcification, aortic valvular calcification, and sinotubular calcification; whereas in the prospective study, serum 25(OH)D level was monitored in patients with known valvular calcification. Serum parathyroid hormone (PTH) was monitored in both studies. Results: In the retrospective study, hypovitaminosis D was found in 19 patients (31{\%}) with valvular calcification and in whom serum PTH was increased (83 ± 8 pg/mL). In the prospective study, 15 of 20 elderly patients (80{\%}) with known DCM and valvular calcification were found to have hypovitaminosis D (25(OH)D <30 ng/mL), whereas serum PTH was normal (43 ± 4 pg/mL). Conclusions: In patients with DCM without marked renal dysfunction, valvular calcification was seen more frequently and associated with hypovitaminosis D, whereas in elderly patients with valvular calcification, hypovitaminosis D is common, suggesting that the duration of vitamin D deficiency may determine the extent of valvular calcification. The role of hypovitaminosis D in the appearance of valvular calcification deserves further study.",
author = "Dwight Dishmon and Dotson, {Jimmy L.} and Ahmad Munir and Nelson, {Maeda D.} and Syamal Bhattacharya and D'Cruz, {Ivan A.} and Davis, {Richard C.} and Karl Weber",
year = "2009",
month = "1",
day = "1",
doi = "10.1097/MAJ.0b013e3181907add",
language = "English (US)",
volume = "337",
pages = "312--316",
journal = "American Journal of the Medical Sciences",
issn = "0002-9629",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Hypovitaminosis D and valvular calcification in patients with dilated cardiomyopathy

AU - Dishmon, Dwight

AU - Dotson, Jimmy L.

AU - Munir, Ahmad

AU - Nelson, Maeda D.

AU - Bhattacharya, Syamal

AU - D'Cruz, Ivan A.

AU - Davis, Richard C.

AU - Weber, Karl

PY - 2009/1/1

Y1 - 2009/1/1

N2 - Background: In patients with dilated (idiopathic) cardiomyopathy (DCM), little is known about the presence of valvular calcification and its association with hypovitaminosis D, which may predispose affected tissues to calcification. Our objectives were 2-fold: to conduct a retrospective assessment of echocardiographic evidence of valvular calcification in patients with DCM who were known to have hypovitaminosis D (25(OH)D <30 ng/mL) and to conduct a prospective assessment of serum 25(OH)D in patients with DCM, who had demonstrated echocardiographic evidence of valvular calcification. Methods: The retrospective study consisted of 48 African American patients (34 men, 14 women; 52.3 ±1.5 years) having DCM and ejection fraction <35% with serum creatinine <2.0 mg/dL and 25(OH)D <30 ng/mL; and 20 white patients in the prospective study (20 men; 71.0 ± 3.0 years) having DCM and ejection fraction <35% with serum creatinine <2.0 mg/dL and echocardiographic evidence of valvular calcification. In the retrospective study, a transthoracic echocardiogram was obtained to address mitral valvular and annular calcification, aortic valvular calcification, and sinotubular calcification; whereas in the prospective study, serum 25(OH)D level was monitored in patients with known valvular calcification. Serum parathyroid hormone (PTH) was monitored in both studies. Results: In the retrospective study, hypovitaminosis D was found in 19 patients (31%) with valvular calcification and in whom serum PTH was increased (83 ± 8 pg/mL). In the prospective study, 15 of 20 elderly patients (80%) with known DCM and valvular calcification were found to have hypovitaminosis D (25(OH)D <30 ng/mL), whereas serum PTH was normal (43 ± 4 pg/mL). Conclusions: In patients with DCM without marked renal dysfunction, valvular calcification was seen more frequently and associated with hypovitaminosis D, whereas in elderly patients with valvular calcification, hypovitaminosis D is common, suggesting that the duration of vitamin D deficiency may determine the extent of valvular calcification. The role of hypovitaminosis D in the appearance of valvular calcification deserves further study.

AB - Background: In patients with dilated (idiopathic) cardiomyopathy (DCM), little is known about the presence of valvular calcification and its association with hypovitaminosis D, which may predispose affected tissues to calcification. Our objectives were 2-fold: to conduct a retrospective assessment of echocardiographic evidence of valvular calcification in patients with DCM who were known to have hypovitaminosis D (25(OH)D <30 ng/mL) and to conduct a prospective assessment of serum 25(OH)D in patients with DCM, who had demonstrated echocardiographic evidence of valvular calcification. Methods: The retrospective study consisted of 48 African American patients (34 men, 14 women; 52.3 ±1.5 years) having DCM and ejection fraction <35% with serum creatinine <2.0 mg/dL and 25(OH)D <30 ng/mL; and 20 white patients in the prospective study (20 men; 71.0 ± 3.0 years) having DCM and ejection fraction <35% with serum creatinine <2.0 mg/dL and echocardiographic evidence of valvular calcification. In the retrospective study, a transthoracic echocardiogram was obtained to address mitral valvular and annular calcification, aortic valvular calcification, and sinotubular calcification; whereas in the prospective study, serum 25(OH)D level was monitored in patients with known valvular calcification. Serum parathyroid hormone (PTH) was monitored in both studies. Results: In the retrospective study, hypovitaminosis D was found in 19 patients (31%) with valvular calcification and in whom serum PTH was increased (83 ± 8 pg/mL). In the prospective study, 15 of 20 elderly patients (80%) with known DCM and valvular calcification were found to have hypovitaminosis D (25(OH)D <30 ng/mL), whereas serum PTH was normal (43 ± 4 pg/mL). Conclusions: In patients with DCM without marked renal dysfunction, valvular calcification was seen more frequently and associated with hypovitaminosis D, whereas in elderly patients with valvular calcification, hypovitaminosis D is common, suggesting that the duration of vitamin D deficiency may determine the extent of valvular calcification. The role of hypovitaminosis D in the appearance of valvular calcification deserves further study.

UR - http://www.scopus.com/inward/record.url?scp=67649126339&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67649126339&partnerID=8YFLogxK

U2 - 10.1097/MAJ.0b013e3181907add

DO - 10.1097/MAJ.0b013e3181907add

M3 - Article

VL - 337

SP - 312

EP - 316

JO - American Journal of the Medical Sciences

JF - American Journal of the Medical Sciences

SN - 0002-9629

IS - 5

ER -